Body weight, gender and response to TNF-α blockers in axial spondyloarthritis

Elisa Gremese; Simone Bernardi; Sara Bonazza; Marcin Nowik; Giusy Peluso; Alfonso Massara; Barbara Tolusso; Laura Messuti; Maria Concetta Miceli; Angelo Zoli; Francesco Trotta; Marcello Govoni; Gianfranco Ferraccioli

doi:10.1093/rheumatology/ket433

Body weight, gender and response to TNF-α blockers in axial spondyloarthritis

Elisa Gremese, Simone Bernardi, Sara Bonazza, Marcin Nowik, Giusy Peluso, Alfonso Massara, Barbara Tolusso, Laura Messuti, Maria Concetta Miceli, Angelo Zoli, Francesco Trotta, Marcello Govoni, Gianfranco Ferraccioli

Risultato della ricerca: Contributo in rivista › Articolo in rivista

74 Citazioni (Scopus)

Abstract

The objective of this study was to determine whether BMI and gender could lead to a different response rate to anti-TNF agents in patients affected by axial SpA.

Lingua originale	English
pagine (da-a)	875-881
Numero di pagine	7
Rivista	Rheumatology
Volume	53
DOI	https://doi.org/10.1093/rheumatology/ket433
Stato di pubblicazione	Pubblicato - 2014

Keywords

Adult
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antirheumatic Agents
Axis
BMI
Body Mass Index
Body Weight
Female
Follow-Up Studies
Humans
Immunoglobulin G
Logistic Models
Male
Middle Aged
Obesity
Overweight
Receptors, Tumor Necrosis Factor
Retrospective Studies
Sex Factors
Spondylarthritis
Treatment Outcome
Tumor Necrosis Factor-alpha
anti-TNF response
axial spondyloarthritis
gender
obesity

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1093/rheumatology/ket433

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{530b72c30d2b4faab0c0dcbd78c98ed5,

title = "Body weight, gender and response to TNF-α blockers in axial spondyloarthritis",

abstract = "The objective of this study was to determine whether BMI and gender could lead to a different response rate to anti-TNF agents in patients affected by axial SpA.",

keywords = "Adult, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Antirheumatic Agents, Axis, BMI, Body Mass Index, Body Weight, Female, Follow-Up Studies, Humans, Immunoglobulin G, Logistic Models, Male, Middle Aged, Obesity, Overweight, Receptors, Tumor Necrosis Factor, Retrospective Studies, Sex Factors, Spondylarthritis, Treatment Outcome, Tumor Necrosis Factor-alpha, anti-TNF response, axial spondyloarthritis, gender, obesity, Adult, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Antirheumatic Agents, Axis, BMI, Body Mass Index, Body Weight, Female, Follow-Up Studies, Humans, Immunoglobulin G, Logistic Models, Male, Middle Aged, Obesity, Overweight, Receptors, Tumor Necrosis Factor, Retrospective Studies, Sex Factors, Spondylarthritis, Treatment Outcome, Tumor Necrosis Factor-alpha, anti-TNF response, axial spondyloarthritis, gender, obesity",

author = "Elisa Gremese and Simone Bernardi and Sara Bonazza and Marcin Nowik and Giusy Peluso and Alfonso Massara and Barbara Tolusso and Laura Messuti and Miceli, {Maria Concetta} and Angelo Zoli and Francesco Trotta and Marcello Govoni and Gianfranco Ferraccioli",

year = "2014",

doi = "10.1093/rheumatology/ket433",

language = "English",

volume = "53",

pages = "875--881",

journal = "Rheumatology",

issn = "1462-0324",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Body weight, gender and response to TNF-α blockers in axial spondyloarthritis

AU - Gremese, Elisa

AU - Bernardi, Simone

AU - Bonazza, Sara

AU - Nowik, Marcin

AU - Peluso, Giusy

AU - Massara, Alfonso

AU - Tolusso, Barbara

AU - Messuti, Laura

AU - Miceli, Maria Concetta

AU - Zoli, Angelo

AU - Trotta, Francesco

AU - Govoni, Marcello

AU - Ferraccioli, Gianfranco

PY - 2014

Y1 - 2014

N2 - The objective of this study was to determine whether BMI and gender could lead to a different response rate to anti-TNF agents in patients affected by axial SpA.

AB - The objective of this study was to determine whether BMI and gender could lead to a different response rate to anti-TNF agents in patients affected by axial SpA.

KW - Adult

KW - Antibodies, Monoclonal

KW - Antibodies, Monoclonal, Humanized

KW - Antirheumatic Agents

KW - Axis

KW - BMI

KW - Body Mass Index

KW - Body Weight

KW - Female

KW - Follow-Up Studies

KW - Humans

KW - Immunoglobulin G

KW - Logistic Models

KW - Male

KW - Middle Aged

KW - Obesity

KW - Overweight

KW - Receptors, Tumor Necrosis Factor

KW - Retrospective Studies

KW - Sex Factors

KW - Spondylarthritis

KW - Treatment Outcome

KW - Tumor Necrosis Factor-alpha

KW - anti-TNF response

KW - axial spondyloarthritis

KW - gender

KW - obesity

KW - Adult

KW - Antibodies, Monoclonal

KW - Antibodies, Monoclonal, Humanized

KW - Antirheumatic Agents

KW - Axis

KW - BMI

KW - Body Mass Index

KW - Body Weight

KW - Female

KW - Follow-Up Studies

KW - Humans

KW - Immunoglobulin G

KW - Logistic Models

KW - Male

KW - Middle Aged

KW - Obesity

KW - Overweight

KW - Receptors, Tumor Necrosis Factor

KW - Retrospective Studies

KW - Sex Factors

KW - Spondylarthritis

KW - Treatment Outcome

KW - Tumor Necrosis Factor-alpha

KW - anti-TNF response

KW - axial spondyloarthritis

KW - gender

KW - obesity

UR - http://hdl.handle.net/10807/64964

U2 - 10.1093/rheumatology/ket433

DO - 10.1093/rheumatology/ket433

M3 - Article

SN - 1462-0324

VL - 53

SP - 875

EP - 881

JO - Rheumatology

JF - Rheumatology

ER -

Body weight, gender and response to TNF-α blockers in axial spondyloarthritis

Abstract

Keywords

OSS delle Nazioni Unite

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo